it is an analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. There have been no published reports of hepatotoxicity attributed to it therapy. it is a 39 amino acid peptide and synthetic version of exendin-4, a hormone found in the saliva of the venomous lizard Gila monster, with insulin secretagogue and antihyperglycemic activity. it is administered subcutaneously and mimics human glucagon-like peptide-1 (GLP-1). Compared to GLP-1, it has a longer half-life of 2.4 hours. 
